IMR Press / EJGO / Volume 21 / Issue 4 / pii/2000193

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Case Report

Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma

Show Less
1 Department of Obstetrics and Gynecology, Miyazaki Prefectural Hospital, Miyazaki, Japan
2 Department of Pathology, Miyazaki Prefectural Hospital, Miyazaki, Japan
Eur. J. Gynaecol. Oncol. 2000, 21(4), 383–386;
Published: 10 August 2000

A 41-year-old multigravida woman presented with a cervical stage lb adenosquamous cell carcinoma with metastasis in a tran­sposed ovary. Twenty-four months following a radical hysterectomy for cervical cancer a CT scan revealed a mass measuring 7x6x4 cm in size lateral to the ascending colon. The pathological diagnosis showed the mass to be metastatic adenocarcinoma in the tran­sposed ovary which was considered to be adenocarcinoma from the previous cervical adenosquamous cell carcinoma. Thereafter, she was administered a combination of mitomycin C, etoposide and cisplatin (MEP) three times. One year following the comple­tion of the chemotherapy she is still alive without any definitive recurrence. It is important to clarify whether or not ovarian tran­sposition is safe and effective in helping surgeons determine whether or not to preserve the ovarian function for a young patient likely to undergo postoperative irradiation for early invasive cervical cancer. In the present report, we also review the current lite­rature on this subject and discuss our findings.

Cervical carcinoma
Ovarian metastasis
Transposed ovary
Back to top